Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China

Journal of Neuro-Oncology

Volumn 73, Issue 3, 2005, Pages 253-260

  Bian, Liu Guan ^a,b   Tirakotai, Wuttipong ^b   Sun, Qing Fang ^a   Zhao, Wei Guo ^a   Shen, Jian Kang ^a   Luo, Qi Zhong ^c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Loss of heterozygosity; NF2 gene mutation; Schwannomin merlin expression; Vestibular Schwannoma

Indexed keywords

CELL NUCLEUS ANTIGEN; DNA MARKER; MERLIN;

ADULT; AGED; ALLELE; ARTICLE; BRAIN RADIOGRAPHY; CHINA; CHROMOSOME 22Q; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR GENETICS; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH; VESTIBULAR DISORDER; WESTERN BLOTTING;

ADULT; AGED; BASE SEQUENCE; BLOTTING, WESTERN; CHINA; CHROMOSOMES, HUMAN, PAIR 22; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, NEUROFIBROMATOSIS 2; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEUROFIBROMIN 2; NEUROMA, ACOUSTIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 22144483064     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-5176-3     Document Type: Article

References (34)

1. C Matthies M. Samii 1997 Management of 1000 vestibular schwannomas (acoustic neuromas): Clinical presentation Neurosurgery 40 1-10 10.1097/ 00006123-199701000-00001 1:STN:280:ByiC38npsFQ%3D 8971818
2. GA Rouleau P Merel M Lutchman M Sanson J Zucman C Marienau K Hoang-Xuan S Demczuk C Desmaze B Plougastel SM Pulst G Lenoir E Bijlsma R Fashold J Dumanski P Jong de D Parry R Eldrige A Aurias O Delattre G. Thomas 1993 Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2 Nature 363 515-521 1:CAS:528:DyaK3sXltlKmsbg%3D 8379998
3. JA Trofater MM MacCollin JL Rutter JR Murrell MP Duyao DM Parry R Eldridge N Kley AG Menon K Pulaski et al. 1993 A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 19 75-826
4. GH Xiao J Chernoff JR. Testa 2003 NF2: The wizardry of merlin Genes Chromosomes Cancer 38 389-399 10.1002/gcc.10282 1:CAS:528:DC%2BD3sXpvVyhtbg%3D 14566860
5. J Sainz ME Baser NK Ragge RA Nelson SM. Pulst 1993 Loss of alleles in vestibular schwannomas: Use of microsatellite markers on chromosome 22 Arch Otolaryngol Head Neck Surg 119 1285-1288
6. Marineau C, Rouleau GA. (1992). Dinucleotide repeat polymorphism at the human CRYB2 gene locus (22q11.2). Nucleic Acids Res 20: 2624
7. C Marineau C Baron O Delattre J Zucman G Thomas GA. Rouleau 1993 Dinucleotide repeat polymorphism at the D22S268 locus Hum Mol Genet 2 3361:CAS:528:DyaK3sXkt1Wqsrc%3D
8. C Marineau M Aubry JP Julien GA. Rouleau 1992 Dinucleotide repeat polymorphism at the D22S264 locus Nucl Acids Res 20 1430
9. M Sainio T Strachan G Blomstedt O Salonen K Setala A Palotie J Palo I Pyykko L Peltonen J. Jaaskelainen 1995 Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in a extended pedigree Neurology 45 1314-1322 1:STN:280:ByqA2c3ktVI%3D 7617190
10. JH Lee V Sundaram DJ Stein SM Kinney DW Stacey M. Golubic 1997 Reduced expression of schwannomin/merlin in human sporadic meningiomas Neurosurgery 40 578-587 10.1097/00006123-199703000-00031 1:STN:280:ByiB3cfgs1c%3D 9055299
11. J Antinheimo SL Sallinen P Sallinen H Haapasalo H Helin N Horelli-Kuitunen M Wessman M Sainio J Jaaskelainen O. Carpen 2000 Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH) Acta Neurochir 142 1099-1105 10.1007/s007010070036 1:STN:280:DC%2BD3M7hsVGmtQ%3D%3D
12. CE Bruder K Ichimura O Tingby K Hirakawa A Komatsuzaki A Tamura Y Yuasa VP Collins JP. Dumanski 1999 A group of schwannomas with interstitial deletion on 22q located outside the NF2 locus shows no detectable mutation in the NF2 gene Hum Genet 104 418-424 1:CAS:528:DyaK1MXjtlekt70%3D 10394935
13. DH Gutmann RT Geist H Xu JS Kim S. Saporito-Irwin 1998 Defects in neurofibromatosis 2 protein function can arise at multiple levels Hum Mol Genet 7 335-345 10.1093/hmg/7.3.335 1:CAS:528:DyaK1cXitFWms7w%3D 9466988
14. RM Irving T Harada DA Moffat DG Hardy JL Whittaker JH Xuereb ER. Maher 1997 Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma Am J Otol 18 754-760 1:STN:280:DyaK1c%2FltlWlsw%3D%3D 9391673
15. LB Jacoby D Jones K Davis D Kronn MP Short J Gusella M. MacCollin 1997 Molecular analysis of the NF2 gene tumor-suppressor gene in schwannomatosis Am J Hum Genet 61 1293-1302
16. KK Mantripragada PG Buckley M Benetkiewicz C De Bustos C Hirvela C Jarbo CE Bruder H Wensman T Mathiesen G Nyberg L Papi VP Collins K Ichimura G Evans JP. Dumanski 2003 High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH Int J Oncol 22 615-622 1:CAS:528:DC%2BD3sXhslKru7s%3D 12579316
17. A Mohyuddin WJ Neary A Wallace CL Wu S Purcell H Reid RT Ramsden A Read G Black DG. Evans 2002 Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas J Med Genet 39 315-322 10.1136/jmg.39.5.315 1:CAS:528:DC%2BD38Xks1yju7Y%3D 12011146
18. C Warren LA James RT Ramsden A Wallace ME Baser JM Varley DG. Evans 2003 Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridization J Med Genet 40 802-806
19. PH Bikhazi AK Lalwani EJ Kim N Bikhazi A Attaie WH Slattery RK Jackler DE. Brackmann 1998 Germline screening of the NF2 gene in families with unilateral vestibular schwannoma Otolaryngol Head Neck Surg 119 1-6 1:STN:280:DyaK1czjslaltg%3D%3D 9674507
20. A De Klein PH Riegman EK Bijlsma A Heldoorn M Muijtjens MA den Bakker CJ Avezaat EC. Zwarthoff 1998 A G→ A transition creates a branch point sequence and activation of cryptic exon, resulting in the hereditary disorder neurofibromatosis 2 Hum Mol Genet 7 393-398 10.1093/hmg/7.3.393 1:STN:280:DyaK1c7jtl2itQ%3D%3D 9466995
21. DH Gutmann MJ Giordano AS Fishback A. Guha 1997 Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas Neurology 49 267-270 1:STN:280:ByiA28rjs10%3D 9222206
22. DM Parry MM MacCollin MI Kaiser-Kupfer K Pulaski HS Nicholson M Bolesta R Eldridge JF. Gusella 1996 Germ-line mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities Am J Hum Genet 59 529-539 1:CAS:528:DyaK28Xls1arsLY%3D 8751853
23. MH Ruttledge AA Andermann CM Phelan JO Claudio FY Han N Chretien S Rangaratnam M MacCollin P Short D Parry V Michels VM Riccardi R Weksberg K Kitamura JM Bradburn BD Hall P Propping GA. Rouleau 1996 Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of diseases Am J Hum Genet 59 331-342 1:CAS:528:DyaK28XkvFGrsrs%3D 8755919
24. JA Harwalkar JH Lee G Hughes SE Kinney M. Golubic 1998 Immunoblotting analysis of schwannomin/merlin in human schwannoma Am J Otol 19 654-659 1:STN:280:DyaK1cvitlyqug%3D%3D 9752976
25. L Sherman HM Xu RT Geist S Saporito-Irwin N Howells H Ponta P Herrlich DH. Gutmann 1997 Interdomain binding mediates tumor growth suppression by the NF2 gene product Oncogene 15 2505-2509 10.1038/sj.onc.1201418 1:CAS:528:DyaK2sXnsFajsLY%3D 9395247
26. AO Stemmer-Rachamimov Y Ino ZY Lim LB Jacoby M MacCollin JF Gusella V Ramesh DN. Louis 1998 Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2 J Neuropathol Exp Neurol 57 1164-1167 1:STN:280:DyaK1M%2FnslCktw%3D%3D 9862639
27. DR Scoles DP Huynh MS Chen SP Burke DH Gutmann SM. Pulst 2000 The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate Hum Mol Genet 9 1561-1574 10.1093/hmg/9.11.1567
28. DR Scoles VD Nguyen Y Qin CX Sun H Morrison DH Gutmann SM. Pulst 2002 Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulation STAT signaling Hum Mol Genet 11 3179-3189 10.1093/hmg/11.25.3179 1:CAS:528:DC%2BD38XptlGgtrw%3D 12444102
29. JT Fraenzer H Pan L Minimo Jr. GM Smith D Knauer G. Hung 2003 Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation Int J Oncol 23 1493-1500 1:CAS:528:DC%2BD3sXpvFymtLw%3D 14612918
30. T Hitotsumatsu T Iwaki T Kitamoto M Mizoguchi SO Suzuki Y Hamada M Fukui J. Tateishi 1997 Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study Acta Neuropathol (Berl) 93 225-232 10.1007/s004010050608 1:STN:280:ByiB3sjgslE%3D
31. DP Huynh V Mautner ME Baser D Stavrou SM. Pulst 1997 Immunohistochemical detection of S/M and neurofibromin in vestibular schwannomas, ependymomas and meningiomas J Neuropathol Exp Neurol 56 382-390 1:CAS:528:DyaK2sXislGrurk%3D 9100669
32. J Zucman-Rossi P Legoix H Der-Sarkissian G Cheret F Sor A Bernardi L Cazes S Giraud E Ollagnon G Lenoir G. Thomas 1998 NF2 gene in neurofibromatosis type 2 patients Hum Mol Genet 7 2095-2101 10.1093/hmg/ 7.13.2095 1:CAS:528:DyaK1cXotVSqsLY%3D 9817927
33. K Ueki C Wen-Bin Y Narita A Asai T. Kirino 1999 Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas Cancer Res 59 5995-5998 1:CAS:528:DC%2BD3cXht1Smtw%3D%3D 10606247
34. AB Bianchi T Hara V Ramesh J Gao AJ Klein-Szanto F Morin AG Menon JA Trofatter JF Gusella BR Seizinger N. Kley 1994 Mutation in transcript isoform of the neurofibrpmatosis 2 gene in multiple human tumor types Nat Genet 6 185-192 10.1038/ng0294-185 1:CAS:528:DyaK2cXitFequ7g%3D 8162073